Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP913865.RAcKhE34m_f37KbTKHwCoPma8e9UFSgmj0WNbTqo04wLE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP913865.RAcKhE34m_f37KbTKHwCoPma8e9UFSgmj0WNbTqo04wLE130_assertion type Assertion NP913865.RAcKhE34m_f37KbTKHwCoPma8e9UFSgmj0WNbTqo04wLE130_head.
- NP913865.RAcKhE34m_f37KbTKHwCoPma8e9UFSgmj0WNbTqo04wLE130_assertion description "[In order to investigate its anti-tumor mechanism, we studied the effects of YSL on CaM protein expression and mRNA level, PI3K activity, PI3K regulatory subunit p85 protein expression and mRNA level, and the mRNA level of PI3K catalytic subunits p110alpha and p110gamma in human hepatocellular carcinoma BEL-7402 xenograft tumors in nude mice.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP913865.RAcKhE34m_f37KbTKHwCoPma8e9UFSgmj0WNbTqo04wLE130_provenance.
- NP913865.RAcKhE34m_f37KbTKHwCoPma8e9UFSgmj0WNbTqo04wLE130_assertion evidence source_evidence_literature NP913865.RAcKhE34m_f37KbTKHwCoPma8e9UFSgmj0WNbTqo04wLE130_provenance.
- NP913865.RAcKhE34m_f37KbTKHwCoPma8e9UFSgmj0WNbTqo04wLE130_assertion SIO_000772 17546603 NP913865.RAcKhE34m_f37KbTKHwCoPma8e9UFSgmj0WNbTqo04wLE130_provenance.
- NP913865.RAcKhE34m_f37KbTKHwCoPma8e9UFSgmj0WNbTqo04wLE130_assertion wasDerivedFrom befree-20150227 NP913865.RAcKhE34m_f37KbTKHwCoPma8e9UFSgmj0WNbTqo04wLE130_provenance.
- NP913865.RAcKhE34m_f37KbTKHwCoPma8e9UFSgmj0WNbTqo04wLE130_assertion wasGeneratedBy ECO_0000203 NP913865.RAcKhE34m_f37KbTKHwCoPma8e9UFSgmj0WNbTqo04wLE130_provenance.